These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18719894)

  • 1. Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling.
    Arnsten AF
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):445-55. PubMed ID: 18719894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.
    Arnsten AF
    Cereb Cortex; 2007 Sep; 17 Suppl 1():i6-15. PubMed ID: 17434919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness.
    Hains AB; Arnsten AF
    Learn Mem; 2008 Aug; 15(8):551-64. PubMed ID: 18685145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.
    Gamo NJ; Arnsten AF
    Behav Neurosci; 2011 Jun; 125(3):282-96. PubMed ID: 21480691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
    Dean B; Gibbons AS; Boer S; Uezato A; Meador-Woodruff J; Scarr E; McCullumsmith RE
    Aust N Z J Psychiatry; 2016 Mar; 50(3):275-83. PubMed ID: 26013316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function.
    Vanderplow AM; Eagle AL; Kermath BA; Bjornson KJ; Robison AJ; Cahill ME
    Neuron; 2021 May; 109(9):1479-1496.e6. PubMed ID: 33765445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder.
    Beasley C; Cotter D; Everall I
    Schizophr Res; 2002 Nov; 58(1):63-7. PubMed ID: 12363391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder.
    Molina V; Sánchez J; Sanz J; Reig S; Benito C; Leal I; Sarramea F; Rebolledo R; Palomo T; Desco M
    Eur Psychiatry; 2007 Nov; 22(8):505-12. PubMed ID: 17904824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
    Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
    J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
    Hahn CG; Friedman E
    Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
    Abrial E; Bétourné A; Etiévant A; Lucas G; Scarna H; Lambás-Señas L; Haddjeri N
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25577667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.
    Farzan F; Barr MS; Levinson AJ; Chen R; Wong W; Fitzgerald PB; Daskalakis ZJ
    Brain; 2010 May; 133(Pt 5):1505-14. PubMed ID: 20350936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
    Einat H; Chen G; Manji H
    Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder.
    Kunii Y; Hino M; Matsumoto J; Nagaoka A; Nawa H; Kakita A; Akatsu H; Hashizume Y; Yabe H
    Sci Rep; 2019 Oct; 9(1):14877. PubMed ID: 31619735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical neurochemistry in euthymic patients with bipolar I disorder.
    Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Paterson C; Wang Y; Hyde TM; Weinberger DR; Kleinman JE; Law AJ
    Am J Psychiatry; 2017 Mar; 174(3):256-265. PubMed ID: 27771971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.
    Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MA; de Moura AB; Matos D; Demo JP; da Silva JB; Michels M; Abatti M; Sonai B; Dal Pizzol F; Carvalho AF; Quevedo J
    J Psychiatr Res; 2017 Apr; 87():81-87. PubMed ID: 28017918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
    Rosenberg G
    Cell Mol Life Sci; 2007 Aug; 64(16):2090-103. PubMed ID: 17514356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
    Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
    J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.